Background: Glutamate is a non-essential amino acid at the crossroads of nitrogen and energy metabolism. Glutamate metabolism is characterized by reactions that may be anabolic or catabolic in nature depending on the tissue (i.e., glutamate dehydrogenase, transaminases), and it can also be either the precursor or the metabolite of glutamine. Unlike glutamine, which is the form of interorgan ammonia transport, glutamate metabolism is mostly compartmentalized within the cells, its interorgan exchanges being limited to a flux from liver to muscle. Summary: Glutamate catabolism is extremely intense in the splanchnic area, such that after a meal (rich in proteins) almost no glutamate appears in the systemic circulation. However, this process is saturable as after glutamate loading at a high dose level, glutamate appears dose-dependently in the circulation. This systemic glutamate appearance is blunted if glutamate is co-ingested with a carbohydrate source. Key Messages: The underlying reason for this highly specific metabolism is that glutamate plays a key role in nitrogen homeostasis, and the organism does all it can to limit the bioavailability of glutamate, which can be neurotoxic in excess. As glutamate is never eaten alone, its bioavailability will be limited if not negligible, and no adverse effects are to be expected in adult humans.
Introduction
L-Glutamic acid (hereafter referred to as glutamate) was discovered by H. Ritthausen in 1866 (in [1] ). On average, 100 g of protein supplies 4-12 g of glutamate [2] . There is slightly more glutamate in plant than in animal proteins, the richest being gliadin (45.7 g of glutamate/100 g of protein) and α-casein (16.5 g of glutamate/100 g of protein), respectively [1] . Glutamate added to a diet is generally in the form of monosodium glutamate (MSG). However, as MSG and all other glutamate salts (additives designated E620-E625) dissociate in aqueous solution and so behave exactly as free glutamate [2] , the latter term will be used. However, to avoid confusion about administered dose in dietary interventions, the form of the glutamate (i.e., free or MSG) will be indicated. Glutamate provides a negative charge, which is important to stabilize the protein structure [3] and leads to several functional entities (see below for details). With its large number of very active metabolic
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Catabolic Reactions
In humans, the main catabolic reaction is a non-oxidative decarboxylation. This reaction is mediated by glutamate decarboxylase located only in the brain [1] and gives rise to γ-aminobutyric acid (GABA):
The decarboxylation of carbon in position 5 can also occur in bacteria but not in human cells [1] . The reaction product is α-aminobutyric acid. The enzyme is glutamate dehydrogenase (GLDH, EC 1.4.1.3), which is located in mitochondria. There is no isoenzyme, but different co-enzymes according to the direction of the reaction: NADPH, H + (for amination) or NADH, H + for de-amination [4] . Of note, the reaction is expressed in 2 steps: first the reduction of NAD + to α-iminoglutaric acid, and second the release of ammonia and α-ketoglutarate [5] . The reaction equilibrium favors glutamate synthesis [4] , but the reaction is close to equilibrium, such that provision/removal of substrates/products is important in the final direction of the reaction [6] . This enzyme is present in a number of organs, mainly in the liver (mostly in perivenous cells) and the kidney, with some differences among species [4] . The preferential zonation of GLDH in perivenous hepatocytes [7] indicates that its major function in the liver is the resynthesis of glutamine rather than the production of NH 4 + for ureagenesis, which is localized in periportal hepatocytes [4] . However, in glucocorticoid-treated rats, there is an increase in both GLDH activity and release of glutamate by the liver [8] . In peripheral tissues, the energy-rich phosphates inhibit GLDH, suggesting that this enzyme plays a key role in cell bioenergetics, that is, increasing α-ketoglutarate disposal when cellular ATP is low [4].
Reactions That
Amidation/De-Amidation Reaction
The reactions from and to glutamine are as follows: To avoid a futile cycle, glutamine synthetase and glutaminase are localized in different cell types (Table 1) . However, the 2 enzymes were shown to be colocalized in the same liver cells in a model of isolated perfused rat liver [9] . There are 2 glutaminase isoenzymes: the liver type and the kidney/brain type [6] . Liver-type glutaminase activity is stimulated by glucagon and epinephrine [6] and by reaction products such as bicarbonate and ammonia [6] . The hepatic glutaminase has the remarkable property of being activated by its own product, ammonia [10] (Fig. 1) . Decreasing pH (i.e., acidosis) inhibits the liver-type enzyme but stimulates the kidney-type gluta-minase activity [6] . In the long term, at the transcriptional level, hepatic glutaminase is increased in diabetes, starvation and a high-protein diet, and is repressed with a low-protein diet [6] . Glutamine synthetase is a cytosolic enzyme expressed in various cell types, in particular perivenous hepatocytes (Table 1) . Unlike glutaminase, glutamine synthetase responds weakly to metabolic or endocrine regulation [6] .
Transamination Reaction
This reaction is general, and present in all tissues. It involves 2 couples of AA/keto acids: one is specific (e.g., aspartate/oxaloacetate, alanine/pyruvate, leucine/α -ketoisocaproate) and the other is common to all transamination reactions: glutamate/α-ketoglutarate. The transamination reaction is therefore an exchange of nitrogen between AAs, and so strictly it is neither anabolic nor catabolic.
The transamination enzymes possess a prosthetic group (pyridoxal phosphate) that binds the AA during the reaction, which follows a ping-pong-type mechanism (see reference [5] for details).
One highly specific transaminase is ornithine aminotransferase (OAT; EC 2.6.1.13), which is found in almost all tissues and in particular in the perivenous hepatocytes [10] where it colocalizes with glutamine synthetase in the mitochondria [11] .
Except in the intestine, OAT promotes the synthesis of glutamate from ornithine (see reference [12] for details):
Ornithine + α-ketoglutarate ⇋ glutamyl 5-semialdehyde + glutamate Of note, glutamyl 5-semialdehyde (G5A) can be cyclized into Δ 1 -pyrroline-5-carboxylate (P5C) and this reaction is not enzymatically mediated (see reference [12] for a recent review on this topic). P5C opens the way to proline and related metabolic pathways [13, 14] through the action of P5C reductase [15] . A tracer study in rats indicates that the contribution of proline carbon to glutamate is ~12% [16] .
In the liver, OAT activity increases after a high-protein diet and is stimulated by glucagon. Conversely, OAT activity is decreased by glucocorticoids [12] .
Other Reactions Leading to Functional Entities
Glutamate is 1 of the 3 AAs comprising glutathione, the first step of its synthesis being the formation of glutamylcysteine by γ-glutamyltransferase [3] .
Glutamate can be post-transcriptionally carboxylated into γ-carboxyglutamic acid in the presence of vitamin K. This reaction occurs mainly in pre-prothrombin in the liver and in osteocalcin in bone. This derivative is functionally very important because it is the site of calcium binding [3] .
Glutamate is acetylated in periportal liver cells. The resulting N-acetylglutamate is an allosteric activator of carbamyl phosphate synthetase I, a key regulatory enzyme in the urea cycle [10, 17] (Fig. 1 ).
Pharmacokinetics of Dietary Glutamate
Rutten et al. [18] administered 30 mg of glutamate/kg body weight (bw) orally every 20 min for 220 min. The plasma glutamate level peaked at 80 min. It is interesting that glutamate levels did not increase beyond this ceiling and remained steady despite further administration every 20 min.
Stegink et al. [19] conducted an impressive series of studies in which glutamate (as monosodium salt) was administered alone, with carbohydrate [19, 20] , with a con- somme [20, 21] or with meals [22, 23] . The results of these studies are summarized in Table 2 .
When administered alone at 150 mg/kg bw in 8 healthy adult subjects in the post-absorptive state, plasma glutamate peaked (14.6 times the basal value) at 30-45 min and returned to basal levels at 120 min post-ingestion. There was no change in glutamate levels in red blood cells [19] . Some years later, Graham et al. [24] conducted a similar study and obtained closely similar results. They administered 150 mg MSG/kg bw orally to 9 healthy young adults (19-49 years) of mean weight 76.9 kg. Blood was sampled every 15 min up to 105 min. Plasma glutamate peaked at 30-45 min (+700-800% above basal) and then declined rapidly (at 90 min not different from basal). There was a transient small but significant increase in 2 AAs (proline, glutamine) metabolically connected to glutamate. There was also a moderate increase in vastus lateralis muscle glutamate level at 45 and 75 min post-injection.
In these and other studies, there was some change in the concentrations of other AAs: ornithine [25] and aspartate [26] .
When MSG (150 mg/kg bw) was given together with carbohydrate (1.1 g/kg bw in the form of hydrolyzed corn starch), time to reach the plasma glutamate peak and time to return to basal were similar to the values observed when glutamate was given alone [19] . However, the peak plasma concentration was lowered ( Table 2 ). The authors [19] suggest that carbohydrate increases the flux of pyruvate in enterocytes, facilitating the transamination of glutamate and therefore the release of alanine instead of glutamate in the portal vein (Fig. 2) . In another study [22] When the same meal was given to 12 healthy adults but with a lower dosage of glutamate (MSG 34 mg/kg bw; total glutamate 196 mg/kg) [23] , there was no difference in plasma glutamate between the 2 experiments (meal and meal + MSG) at any time point, but the plasma peak of glutamate was considerably delayed ( Table 2) .
In another study [20] , 50 mg MSG/kg bw was given to 6 healthy adults (mean weight: 73.4 kg) with a beef consomme (supplying protein 6.4%, fat 11.3% and sugar 22.5% dry weight) with or without sucrose. In the presence of sucrose, appearance of glutamate was strongly blunted (Table 2) and there was a marked rise in alanine (+50% versus basal), which was not observed in the absence of sucrose.
In the last study by these authors [21] , the same consomme was given to 9 healthy subjects, alone or with 25 or 50 mg MSG/kg bw. Plasma glutamate rose dose-dependently (Table 2) reaching a peak at 30 min.
In mice in the postprandial state, after a bolus gavage of 1 g MSG/kg bw, glutamate in plasma peaked at 15 min and had returned to basal at 120 min. Alanine peaked (+ 50% vs. basal) at 30 min post-MSG ingestion [27] . In pigs, after ingestion of a meal containing 10 g MSG (i.e., ~167 mg/kg bw), plasma glutamate peaked at 60 min and then slowly decreased without returning to the basal value at 360 min. This was accompanied by an increase in plasma aspartate [26] .
In male Sprague-Dawley rats, the administration of an MSG load (250 mg/kg) directly into the stomach led to a glutamate peak in plasma at 15 min and a return to baseline at 60 min. Carbohydrate ingestion before glutamate loading blunted glutamate appearance in blood as in humans, but the increase in plasma alanine was low (though significant), independent of carbohydrate administration before loading [28] . Taken together, the data suggest metabolic differences according to the dose administered, higher doses likely promoting glutamate transamination in the gut up to a break-event point (i.e., saturation of the pathway).
The major splanchnic extraction of glutamate after oral/enteral glutamate administration is further exemplified in the pharmacokinetics of glutamate administered intravenously (i.v.): a load (over 10 min) of 11.45 g MSG was given to 7 subjects considered healthy and weighing 75 ± 5 kg. At the end of the plasma perfusion, glutamate levels were around 1,100 µmol/L [29] . Perfusing 36.8 mg glutamate/kg bw over 1 h to cardiovascular surgical patients led to a glutamate plasma concentration of 555 ± 177 µmol/L (mean ± SD) and a positive glutamate uptake in the leg (6.8 times basal, we note that in the basal state there was still a small but significant uptake) [30] . In another study [31] , an i.v. bolus administration of 1.2, 2.5, or 5 mg MSG/kg bw to subjects considered healthy induced a maximum glutamate plasma concentration of 184 ± 12, 234 ± 14, and 397 ± 30 µmol/L respectively.
Metabolism of Dietary Glutamate
Intestinal Absorption and Metabolism
At the enterocyte surface, there is a specific transporter for dicarboxylic AAs (i.e., glutamic acid and aspartic acid) that is Na + -dependent and saturable [1] and a Na + -independent carrier [2] . In the human jejunum, it has been shown [32] that this transporter works by exchanging Na + (inward gradient).
The intestine is the primary site of ingested glutamate metabolism. Pioneering ex vivo and in vivo studies of the 1950s (in [1] ) in rats and dogs indicated that when glutamate was instilled in the intestine, it was alanine that appeared in the portal blood, indicating that glutamate is highly transaminated in the enterocyte, and this fact was confirmed more recently in humans using stable isotopes [33] . Actually, > 90% of the dietary glutamate presented to the mucosa is metabolized in first pass in adult rats [34] . 15 N is incorporated into various AAs, mainly alanine, proline, and citrulline [35] . After transamination, the carbon moiety of glutamate is totally oxidized or incorporated to form other AAs, mainly alanine [35, 36] .
Cellular Uptake
In rat myotubes in cultures, 2 transport systems have been identified for glutamate: one is Na + -dependent, has a low affinity for glutamate (K m ≈ 0.7 mM) and is upregulated when cells are glutamine-deprived; the other is Na + -independent and is inhibited by cysteine but not aspartate, which are features characteristic of system X c - [37] . This latter system is also found in human fibroblasts, which also display 2 Na + -dependent systems, of high and low affinity, respectively (system X ag -shared with aspartate, and system ASC [Aspartate, Serine, Cysteine]) [38] . In hepatocytes, the transport is mainly Na + -dependent in perivenous cells and Na + -independent in periportal cells [6, 39] . In the former cells, transport activity is about 20 times higher than in the latter (in [40] ) and resembles the Xag transporter [39] .
Appearance of Glutamate in Portal Vein and Liver Metabolism
As indicated above, glutamate is highly metabolized in the intestine. Interestingly this process appears to be saturable because if the level of perfused glutamate increases, it appears in the portal vein [26] : after a protein-rich meal, small amounts of glutamate therefore appear in portal blood and are taken up by the liver. In rats, on administering 13 N-glutamate in the portal vein [41] or 15 N-glutamate intravenously [42] , the label appears within seconds in liver alanine and aspartate, underlining the importance of transamination reactions. As a consequence, very little glutamate appears in the systemic blood after a meal [43] . These data agree with the results of pharmacokinetic studies (see above for details).
Glutamine catabolism in periportal hepatocytes provides ammonia for ureagenesis and glutamate for gluconeogenesis [6] (Fig. 3) .
Conversely, perivenous hepatocytes (a small population representing 7% of all hepatocytes of an acinus [44] ) contain glutamine synthetase allowing glutamine synthesis from glutamate [7] . The underlying reason for this tight metabolic organization is to remove ammonia in response to any of the situation [44] (Fig. 3) .
For example, when adult Wistar rats were adapted for 21 days to a slightly protein-deficient diet (11% casein) or a moderately protein-surfeit diet (22% casein), glutamate release by the liver was only non-significantly higher in the 22% than in 11% casein-fed rats in the post-absorptive state, and significantly decreased only in the 22% casein group in the postprandial state [44] . These data clearly show that the liver buffers extra nitrogen by an increase in ureagenesis.
In an experimental study, adult Wistar rats were fed with a 15% casein diet supplemented with 6.1 g of glutamate/kg bw/day for 15-21 days. At the end of the experiment, liver glutamate content was 23% higher in supplemented than in control rats, and alanine was lower (-20%) [45] .
Systemic Glutamate Metabolism
Appearance of Glutamate in Systemic Circulation
Glutamate concentration is much higher (×4) in red blood cells than in plasma, but exchanges between these 2 pools are extremely limited [28, 46, 47] . However, red blood cells could contribute to glutamate delivery to muscle (≈20% of the total, in the heart) [48] .
Tracer studies indicated that most glutamate (88 ± 2%) given nasogastrically at 1.47 mg/kg bw/h to healthy adults, in the post-absorptive state, was sequestered by the splanchnic bed [49] . Similar results were found in other studies [36, 50] using either 13 C-or 15 N-labeled glutamate.
When glutamate was given orally to healthy adults after an overnight fast, at a similar dosage (1.37 mg/kg bw) but as a single bolus, almost no 15 N-glutamate was found in arterialized blood and 15 N was recovered as glutamine and alanine [33] . In the experimental study [45] described above, glutamate arterial levels were 55% higher in supplemented than in control animals. This result may be explained by the fact that the glutamate dosage was very high (even considering that requirements are 10 times higher in rodents than in humans), and that glutamate was given for a long time.
Muscle Metabolism
In myocytes, the fate of glutamate is: 1. To participate in a series of transamination reactions allowing alanine synthesis. The ultimate N-donors in these transamination reactions are branched-chain AAs [5] (Fig. 3) . However, of note, these latter AAs can also provide carbons for the neosynthesis of glutamate [51] . This is certainly the primary fate of glutamate in muscle [47] (Fig. 4) .
2. To be aminated to glutamine by glutamine synthetase. In the post-absorptive state and in most pathological conditions [52] , both alanine and glutamine are released into the bloodstream. In vitro experiments in rats indicate that muscle glutamine synthetase activity is increased when the culture medium contains high glutamate concentrations or when the rats are treated with dexamethasone [53] (Fig. 4) .
Following a supplementation with 6.1 g of glutamate/ kg bw/day in rats ( [45] , see above for details), a large part of the glutamate appearing in the systemic circulation is found in muscles (+16% vs. control). Also, glutamine and alanine in muscle are significantly increased compared to control (+24 and +33 % respectively).
Giving intravenously 1.2, 2.5 or 5 mg MSG/kg bw as a bolus to subjects considered healthy, there was a dosedependent increase in muscle glutamate uptake [31] .
However, following repeated administration of glutamate (30 mg/kg bw every 20 min for 80 min) in healthy adults, muscle glutamate content was unchanged [54] .
Adipose Tissue
Like muscle, adipose tissue takes up glutamate and releases glutamine [55] .
Kidney
There are marked differences according to species: glutamine synthetase is known to exist in the kidney of rodents and sheep but not in that of the human, dog, pig or cat [56] .
Glutamate is a competitive inhibitor of phosphate-dependent glutaminase [57] . During acidosis, the high number of protons in the lumen causes ammonia to be trapped as ammonium ion, which cannot return to cells. This lowers the intracellular ammonia level and promotes the activity of GLDH. This in turn decreases the glutamate levels, which reduces glutaminase [5] (Fig. 5 ). This is a typical process where the use of the final product (i.e., ammonia) pulls the whole pathway in a single direction (i.e., glutamine → glutamate → α-ketoglutarate → ammonia → ammonium ion).
Brain
The fate of glutamate in the brain is discussed in another article in this issue of the Journal. 
Interorgan Exchanges in Health and Disease
Although glutamate comprises around 20% of all AAs in natural proteins and is one of the AAs present at the highest level in its free form in muscle, liver, and kidney (2-5 mmol/L), its concentration in plasma is relatively low (0.05 mmol/L) [10] and stable throughout the fasting and feeding periods in the 24-h day [58] .
In addition, its turnover is relatively low (i.e., 83 ± 22 µmoL/kg/h [46, 59] , less than 25% of that of glutamine in the same perfusion conditions [47] . Taken together, these data suggest that glutamate inter-organ exchanges are low (unlike those of glutamine) and that glutamate metabolism is partitioned within organs [24, 60, 61] .
Of note, glutamate has the unique property among AAs of being released by the liver and taken up by muscles in a wide range of situations including the post-absorptive state [47, 62] , starvation of overweight subjects [62] and in sepsis [63] .
During metabolic acidosis, glutamate metabolism greatly adapts to increase in the provision of ammonia to the kidney: glutaminase in periportal hepatocytes is inhibited and flux of ammonia in perivenous cells is increased, while glutaminase is activated in the kidney [5] (Fig. 3) . However, it is the inter-organ exchanges of glutamine, not of glutamate that are modified, the change in flux of the latter being exclusively intracellular.
In chronic obstructive pulmonary disease patients, the plasma concentrations and appearance of glutamate after glutamate ingestion were lower than in age-matched healthy subjects, suggesting an increase in splanchnic extraction of glutamate in these patients [18] . However, this disease-related difference in glutamate levels was not confirmed in a further study from the same group [54] . Experimental endotoxemia also leads to glutamate sequestration in the splanchnic area [64] .
The fact that glutamate (orally or parenterally) stimulates insulin secretion in the fed state [65] , and in particular when administered with a glucose load [2] , must be considered as a factor that can modulate the tissue processing of glutamate and other related AAs, especially alanine.
As glutamate metabolism is tightly partitioned, it is likely that the fate of glutamate taken up by a cell is different from the fate of glutamate derived from glutamine. For example, glutamate incorporated into glutathione comes from glutamine, whereas glutamate taken up by muscle is mainly directed to transamination reactions (see above for details). Hence, it is not reasonable to take the behavior of glutamate derived from glutamine as representative of glutamate metabolism following dietary glutamate intake. Articles on this topic (e.g., [66] ) cannot therefore be considered here.
Conclusion
Glutamate appears to be a key player in nitrogen salvage, redistribution, and/or elimination according to the tissue and the physiopathological condition. The metabolism of dietary glutamate results in a very limited glutamate appearance in the systemic blood, in particular after a glutamate-rich meal/load, which prevents systemic adverse effects. In real life, MSG is not eaten alone, and any safety recommendations on glutamate intake must take this fact into account.
In addition, the organism limits the inter-organ exchanges of glutamate through a low activity of its transport systems and a high intracellular metabolism.
